Brugada P, Brugada R, Brugada J
Cardiovascular Center, OLV Hospital, Moorselbaan 164, 9300 Aalst, Belgium.
Curr Cardiol Rep. 2000 Nov;2(6):507-14. doi: 10.1007/s11886-000-0035-0.
The Brugada syndrome is a hereditary disease causing sudden cardiac death in apparently healthy individuals with a structurally normal heart. The disease is caused by mutations in the cardiac sodium channel gene SCN5A. Patients with this disease have a peculiar electrocardiogram with elevation of the ST segment in leads V1 to V3, an electrocardiogram that every doctor should recognize. There exist variants of the electrocardiogram with minimal ST segment elevation and even concealed forms that can only be unmasked by the administration of class I antiarrhythmic drugs. When left untreated or when treated with all known antiarrhythmic drugs, patients with Brugada syndrome have a high mortality (approximately 10% per year). The only effective treatment to prevent sudden death is the implantable defibrillator.
Brugada综合征是一种遗传性疾病,可导致心脏结构正常的貌似健康的个体发生心源性猝死。该疾病由心脏钠通道基因SCN5A的突变引起。患有这种疾病的患者有特征性心电图表现,即V1至V3导联ST段抬高,每位医生都应认识这种心电图表现。存在ST段抬高极小的心电图变异型,甚至存在仅通过应用I类抗心律失常药物才能揭示的隐匿型。当不进行治疗或使用所有已知的抗心律失常药物治疗时,Brugada综合征患者有很高的死亡率(每年约10%)。预防猝死的唯一有效治疗方法是植入式除颤器。